cdk4/6 inhibitors in hormone receptor-positive, her2-negative metastatic breast cancer
Published 5 years ago • 872 plays • Length 4:52Download video MP4
Download video MP3
Similar videos
-
1:25
current state of cdk4/6 inhibitors in metastatic her2-negative breast cancer
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
4:50
expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
26:08
metastatic hormone positive breast cancer | 2023 ku breast cancer year in review conference
-
5:56
cdk 4/6 inhibitors for older women with hr-positive breast cancer
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
2:19
cdk 4/6 inhibitors for patients with recurrent er /her2- breast cancer: 2023 best of breast
-
5:16
cdk4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in hr-positive/her2-nega...
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
8:24
cdk4/6 inhibition in hormone receptor-positive mbc
-
2:22
cdk4/6 inhibitors in early stage hr /her2- disease
-
1:09:24
raising the bar in hr /her2- early breast cancer: cdk4 and 6 inhibitors
-
4:45
cdk4/6 inhibitors for hr metastatic breast cancer
-
7:58
cdk 4/6 inhibitors for older women with hr-positive breast cancer
-
4:17
cdk4/6 inhibitors & endocrine therapy in breast cancer
-
1:11
dr. accordino on the utility of cdk4/6 inhibitors in hr /her2– breast cancer
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
1:57
impact of cdk4/6 inhibitors on hr-positive, her2-negative advanced breast cancer